Clinical trial
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
NCT01413061 is registered in ClinicalTrials.gov with AlloSource as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
- Lead sponsor
- AlloSource
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- March 31, 2018
- Enrollment
- 140 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative osteoarthritis, post-traumatic; arthrosis, rheumatoid arthritis & other inflammatory polyarthropathies, rheumatoid arthritis of subtalar joint